Jan 22, 2024 · SMARCA4 deficient uterine sarcomas (SDUS) are molecularly defined by inactivating SMARCA4 mutations, which are associated with SMARCA4 / BRG1 and …

Jul 26, 2023 · E. SMARCA4 / BRG1. SCCOHT is molecularly defined by inactivating SMARCA4 mutations, which are associated with SMARCA4 / BRG1 nuclear loss of expression. The other …

Sep 30, 2021 · SMARCA4 deficient uterine sarcoma: Uniform epithelioid cells with moderate nuclear atypia and eosinophilic cytoplasm, arranged in solid sheets Phyllodiform growth may …

Apr 27, 2021 · SMARCA4 (BRG1), SMARCA2 (BRM) or SMARCB1 (INI1) aberrant loss (Dis Esophagus 2009;22:1, Am J Surg Pathol 2021;45:414) Sample pathology report Esophagus, …

O-Z: perivascular epithelioid cell tumor (PEComa) POLE ultramutated endometrial carcinoma progestin therapy related changes serous carcinoma SMARCA4 deficient uterine sarcoma …

SMARCA4 deficient undifferentiated tumor: Focal rhabdoid morphology Loss of SMARCA4 (BRG1) Large B cell lymphoma / primary mediastinal large B cell lymphoma: Discohesive …

Aug 8, 2023 · Squamous cell carcinoma is a malignant tumor arising from epithelial cells with squamous differentiation demonstrated either immunohistochemically or morphologically, with …

Feb 17, 2022 · Commonly shows an inactivating mutation in one of the core SWI / SNF complex genes, resulting in the loss of expression of BRG1 (SMARCA4 gene), INI1 (SMARCB1 gene) …

Feb 27, 2023 · SMARCA4 loss of function: 5% (Ann Diagn Pathol 2017;26:47) Molecular / cytogenetics images. Contributed by ...

Apr 11, 2025 · Soft tissue: AE1 / AE3 ALK1 caldesmon CAMTA1 CCNB3 (pending) CD31 CD34 CD99 CDK4 D2-40 DDIT3 (pending) desmin DOG1 DUX4 EBER EMA ERG factor XIIIa FLI1 …